CHEN ISAN 4
4 · Mirati Therapeutics, Inc. · Filed Jan 31, 2020
Insider Transaction Report
Form 4
CHEN ISAN
Chief Medical & Dev't Officer
Transactions
- Exercise/Conversion
Common Stock
2020-01-29$24.99/sh+3,002$75,020→ 39,401 total - Exercise/Conversion
Stock Options
2020-01-29−3,002→ 56,754 totalExercise: $24.99Exp: 2026-01-21→ Common Stock (3,002 underlying)
Footnotes (2)
- [F1]1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of theshares subject to the Option shall vest each month thereafter until fully vested.
- [F2]Includes 392 shares acquired under the ESPP Purchase on 05/31/2019 and 171 shares acquired under the ESPP purchase on 11/29/2019.